- Home
- XNCR vs KARO Comparison
XNCR vs KARO Comparison
Compare XNCR & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- KARO
- Stock Information
- Founded
- XNCR 1997
- KARO 2001
- Country
- XNCR United States
- KARO Singapore
- Employees
- XNCR N/A
- KARO N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- KARO Computer Software: Prepackaged Software
- Sector
- XNCR Health Care
- KARO Technology
- Exchange
- XNCR Nasdaq
- KARO Nasdaq
- Market Cap
- XNCR 1.7B
- KARO 1.4B
- IPO Year
- XNCR 2013
- KARO 2021
- Fundamental
- Price
- XNCR $20.45
- KARO $45.16
- Analyst Decision
- XNCR Strong Buy
- KARO Buy
- Analyst Count
- XNCR 9
- KARO 3
- Target Price
- XNCR $36.33
- KARO $39.00
- AVG Volume (30 Days)
- XNCR 766.2K
- KARO 41.1K
- Earning Date
- XNCR 02-25-2025
- KARO 01-14-2025
- Dividend Yield
- XNCR N/A
- KARO 2.39%
- EPS Growth
- XNCR N/A
- KARO 31.10
- EPS
- XNCR N/A
- KARO 1.58
- Revenue
- XNCR $85,164,000.00
- KARO $245,969,394.00
- Revenue This Year
- XNCR N/A
- KARO $10.02
- Revenue Next Year
- XNCR $80.86
- KARO $14.46
- P/E Ratio
- XNCR N/A
- KARO $28.57
- Revenue Growth
- XNCR N/A
- KARO 9.99
- 52 Week Low
- XNCR $15.31
- KARO $23.35
- 52 Week High
- XNCR $27.24
- KARO $50.54
- Technical
- Relative Strength Index (RSI)
- XNCR 38.80
- KARO 47.02
- Support Level
- XNCR $19.15
- KARO $43.50
- Resistance Level
- XNCR $24.66
- KARO $48.74
- Average True Range (ATR)
- XNCR 1.14
- KARO 2.59
- MACD
- XNCR -0.37
- KARO -0.47
- Stochastic Oscillator
- XNCR 24.96
- KARO 23.57
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About KARO Karooooo Ltd.
Karooooo Ltd is a global provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.